Sign In
Buy ETON
$27.61
+0.210 (+0.766%)
At Close: Jun 03, 2026
Strength Seen in Eton Pharmaceuticals, Inc. (ETON): Can Its 13.1% Jump Turn into More Strength?
09:04am, Friday, 16'th Apr 2021
Eton Pharmaceuticals, Inc. (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
04:05pm, Wednesday, 17'th Mar 2021
DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare disease
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2020 Results - Earnings Call Transcript
10:24pm, Tuesday, 16'th Mar 2021
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2020 Results - Earnings Call Transcript
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
06:11pm, Tuesday, 16'th Mar 2021
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -23.08% and -92.21%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for t
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
04:02pm, Tuesday, 16'th Mar 2021
DEER PARK, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare disease
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
04:05pm, Tuesday, 16'th Feb 2021
DEER PARK, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rar
Eton Pharmaceuticals Offloads Neurology Portfolio To Azurity Pharmaceuticals For $45M
09:28am, Monday, 08'th Feb 2021
Eton Pharmaceuticals Inc (NASDAQ: ETON) has sold its neurology portfolio that includes lamotrigine (ET-105), zonisamide (ET-104), and topiramate (ET-101) product candidates, to Azurity Pharmaceuti
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08:00am, Monday, 08'th Feb 2021
DEER PARK, Ill., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rar
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
08:00am, Thursday, 14'th Jan 2021
DEER PARK, Ill., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rar
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution
08:00am, Thursday, 17'th Dec 2020
Application Assigned a PDUFA Date of August 6, 2021 Application Assigned a PDUFA Date of August 6, 2021
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q3 2020 Results - Earnings Call Transcript
10:38pm, Thursday, 12'th Nov 2020
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q3 2020 Results - Earnings Call Transcript
Pool-Supplies Retailer Leslie’s Expects to Raise $410 Million From IPO
04:39pm, Thursday, 22'nd Oct 2020
Leslie’s Inc., the holding company that through subsidiaries sells chemicals for pool and spa maintenance, expects to sell 30 million shares at between $14 and $16 apiece in its initial public offer
Ann Taylor Parent Gets Higher Bid for Tween Brand Justice
07:46pm, Wednesday, 21'st Oct 2020
Ascena Retail Group Inc., the parent company of apparel retailers Ann Taylor and Lane Bryant, received a new, higher stalking horse offer to buy the intellectual property, e-commerce business and othe
Is Copper-Gold Indicator Breaking Out Again?
12:00am, Wednesday, 21'st Oct 2020
Commodities Analysis by Chris Kimble covering: Freeport-McMoran Copper & Gold Inc, Copper Futures, Materials Select Sector SPDR® Fund, iShares 20+ Year Treasury Bond ETF. Read Chris Kimble's latest a
Creditors Brace for Possible Debt Restructuring at Sinclair Sports Unit
11:08pm, Tuesday, 20'th Oct 2020
Sinclair Broadcast Group’s regional sports business and its creditors are preparing for a possible restructuring of its roughly $8 billion debt load, a sign of the pressure on the sports industry fr
